Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating biomarkers associated with response to subsequent therapies in HER2-positive metastatic breast cancer; study termin…
-
FDA approval · 2021-09-15FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kisqali (ribociclib) from Novartis Pharmaceuticals Corporation, expanding its labeling for u…
-
FDA approval · 2021-09-15FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to offer Kisqali (ribociclib) and Femara (letrozole) in a co-pack, enabling joint packaging for appr…
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Accuracy of VABB Elite 10G Versus BARD 14G CNB [Phase 3]
Phase 3 trial update comparing accuracy of VABB Elite 10G versus BARD 14G core needle biopsy in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide [Phase 2]
Phase 2 trial evaluating pembrolizumab in lymphopenic metastatic breast cancer patients treated with metronomic cyclophosphamide has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-09-10Clinical Trial Update: Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating melatonin cream for acute radiation dermatitis in patients with early breast cancer has been completed.
-
FDA approval · 2021-09-09FDA Approved: TALZENNA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TALZENNA (talazoparib) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine [Phase 4]
Phase 4 clinical trial comparing preoperative skin preparation with chlorhexidine versus povidone-iodine for wound infections in breast canc…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating nivolumab combined with eribulin in HER2-negative metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial of palbociclib with letrozole and trastuzumab in stage II-III ER+, HER2+ breast cancer was terminated; results pos…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women [NA]
A completed randomized trial evaluating whether letters from family physicians to encourage overdue women to undergo mammography improve scr…
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: The Prone to Supine Breast MRI Trial [NA]
A completed clinical trial investigating prone vs. supine breast MRI; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine [Phase 3]
Phase 3 trial comparing etirinotecan pegol (NKTR-102) to physician's choice in metastatic breast cancer with stable brain metastases; study …
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib [Phase 2]
A Phase 2 clinical trial evaluating digital PCR screening of plasma HER2 amplification in advanced breast cancer patients treated with trast…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetics and safety assessment of different forms of AZD9496 in healthy subjects with breast cancer as the condition studied…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer [Phase 4]
Phase 4 trial investigating abemaciclib plus fulvestrant versus chemotherapy in HR-positive, HER2-negative metastatic breast cancer; study t…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. [Phase 3]
Phase 3 clinical trial investigating a novel quadruple combination therapy (mifepristone, tamoxifen, retinoic acid, cannabidiol selective CY…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor-positive…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Breast Cancer: Feasibility of an Educational Intervention [NA]
Feasibility study of an educational intervention for breast cancer-related outcomes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer [Phase 1, Phase 2]
Phase 1/2 safety study of hMN14 for colorectal cancer and breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Photobiomodulation for Breast Cancer Radiodermatitis [Phase 2, Phase 3]
Clinical trial update for photobiomodulation in breast cancer radiodermatitis shows completed Phase 2/Phase 3 study.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin [Phase 2]
Phase 2 trial evaluating FCN-437c in combination with fulvestrant or letrozole+goserelin for breast neoplasms (breast cancer) with efficacy,…
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Breast Cancer, Omics, and Precision Medicine [Phase 2]
Phase 2 clinical trial update focusing on breast cancer, omics, and precision medicine.
-
FDA approval · 2021-08-13FDA Approved: FULVESTRANT — Original Application (Northstar Rx, LLC,)
FDA approved a generic fulvestrant from Northstar Rx through an Original Application (ANDA 213553). This approval establishes a generic vers…
-
FDA approval · 2021-08-13FDA Approved: LEUPROLIDE ACETATE — Original Application (NorthStar RxLLC)
FDA approved the Leuprolide acetate original application (ANDA213829) for a generic version, issued to NorthStar RxLLC.